Larimar Therapeutics Inc. buy Quitte
Start price
04.10.16
/
50%
€37.88
Target price
31.01.17
€44.38
Performance (%)
17.14%
End price
31.01.17
€44.38
Summary
This prediction ended on 31.01.17 with a price of €44.38. The prediction had a final performance of 17.14%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | 7.453% | 7.453% | 7.453% | 16.107% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by Quitte for this prediction
In the thread Zafgen Inc. diskutieren